SCHEMBL29425630

SCHEMBL29425630

Cc1c(Cl)cc(NC(=O)[C@H]2[C@H](c3ccc(F)c(Cl)c3)C2(Cl)Cl)cc1C(=O)Nc1ccc(F)c(N)c1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.40
KMT2A Q03164 6/20 0.40
ALDH1A1 P00352 1/20 0.40
RECQL P46063 1/20 0.40
LMNA P02545 4/20 0.39
HTT P42858 5/20 0.39
HPGD P15428 1/20 0.39
FADS1 O60427 1/20 0.37
MAPT P10636 2/20 0.37
MAPK1 P28482 1/20 0.37
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
CHRNA7 P36544 1/20 0.33
PIM1 P11309 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20050826 1.00 MEN1 (0.40) MEN1KMT2AALDH1A1RECQLLMNA
SCHEMBL20050662 0.95 MEN1 (0.40) MEN1KMT2AALDH1A1RECQLLMNA
SCHEMBL30961656 0.92 HTT (0.42) MEN1KMT2AALDH1A1RECQLLMNA
SCHEMBL20050907 0.92 HTT (0.42) MEN1KMT2AALDH1A1RECQLLMNA
SCHEMBL20050666 0.90 HTT (0.41) MEN1KMT2AALDH1A1RECQLLMNA
SCHEMBL20050819 0.90 KMT2A (0.40) MEN1KMT2AALDH1A1RECQLLMNA
SCHEMBL20050653 0.90 KMT2A (0.40) MEN1KMT2AALDH1A1RECQLLMNA
SCHEMBL18147214 0.89 KMT2A (0.43) MEN1KMT2AALDH1A1RECQLLMNA
SCHEMBL29995366 0.89 KMT2A (0.43) MEN1KMT2AALDH1A1RECQLLMNA
SCHEMBL20050307 0.89 MEN1 (0.44) MEN1KMT2AALDH1A1RECQLLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250228239-A1 MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO CORTEVA AGRISCIENCE LLC (US) 2025-07-17 US disclosed
US-11944099-B2 Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto CORTEVA AGRISCIENCE LLC (US) 2024-04-02 US disclosed
EP-3964495-A1 MOLECULES HAVING PESTICIDAL UTILITY, AND COMPOSITIONS, AND PROCESSES, RELATED THERETO Dow AgroSciences LLC (US) 2022-03-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11944099-B2 Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto ACHE, DDT, MLYCD MEN1 1180/4885KMT2A 2615/4885ALDH1A1 443/4885
US-20250228239-A1 MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO ACHE, DDT, MLYCD MEN1 1180/4885KMT2A 2615/4885ALDH1A1 443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.